tm logo
AMNIOGUARD
Live/Registered
REGISTERED AND RENEWED

on 13 Jul 2024

Last Applicant/ Owned by

7300 CORPORATE CENTER DRIVE, SUITE 700

MIAMI

FL

33126

Serial Number

85865795 filed on 04th Mar 2013

Registration Number

4527971 registered on 13th May 2014

in the Principal Register

Correspondent Address

Chloe M. Delehanty

Chloe M. Delehanty WILSON SONSINI GOODRICH & ROSATI

Palo Alto, CA 94304-1050

United States

Filing Basis

1. filed as use application

2. use application currently

Disclaimer

NO DATA

AMNIOGUARD

Human amniotic membrane tissue preparations intended for surgical implantation and dressings; pharmaceutical preparations and substances for the treatment of damaged eye surface, skin and other tissue; pharmaceutical preparations for wounds

Classification Information


Class [005]
Pharmaceutical Products


Human amniotic membrane tissue preparations intended for surgical implantation and dressings; pharmaceutical preparations and substances for the treatment of damaged eye surface, skin and other tissue; pharmaceutical preparations for wounds


First Use Date in General

30th Sep 2010

First Use Date in Commerce

30th Sep 2010

Mark Details


Serial Number

No 85865795

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 34157-TM1006

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
29th Aug 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
13th Jul 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
13th Jul 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
13th Jul 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
13th Jul 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
16th Apr 2024TEAS SECTION 8 & 9 RECEIVED
13th May 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08th Jun 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
22nd Jul 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
22nd Jul 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.